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Abstract The 12(S)-lipoxygenase (12-LOX) pathway of ara-
chidonic acid (AA) metabolism after dioxygenation to 12(S)-
hydroperoxy-eicosatetraenoic acid is bifurcated in a reduction
route to formation of 12(S)-hydroxy-eicosatetraenoic acid (12-
HpETE) and an isomerization route to formation of hepoxilins.
Interestingly, we found that the rat insulinoma RINm5F cells,
which are devoid of cytoplasmic glutathione peroxidase (cGPx)/
phospholipid hydroperoxide glutathione peroxidase (PHGPx),
produce solely hepoxilin A3 (HXA3). Since HXA3 synthesis
was abolished in heat-denatured or cGPx- or PHGPx-trans-
fected cells, it was tempting to speculate that a HXA3 synthase
activity regulated by cGPx/PHGPx is present. To con¢rm this
assumption we incubated AA with HeLa cells overexpressing
the rat leukocyte-type 12-LOX. Neither HXA3 nor 12(S)-
HETE were detected due to abundance of cGPx/PHGPx.
But, pretreatment of transfected cells with diethyl maleate, an
inhibitor of glutathione and PHGPx, restored HXA3 synthase
and 12-LOX activities. Thus, we conclude, that cells containing
rat leukocyte-type 12-LOX also possess an intrinsic HXA3 syn-
thase activity, which is activated by inhibition of cGPx/PHGPx.
In normal cells HXA3 is down-regulated by cGPx/PHGPx, but,
it is persistently activated in oxidatively stressed cells de¢cient
in cGPx/PHGPx, such as RINm5F.
3 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
Key words: Arachidonic acid;
Cytoplasmic glutathione peroxidase;
Phospholipid hydroperoxide glutathione peroxidase;
Hepoxilins; Hepoxilin A3 synthase;
Leukocyte-type 12(S)-lipoxygenase; RINm5F cells
1. Introduction
The 12(S)-lipoxygenase (12-LOX) pathway of arachidonic
acid (AA) metabolism after the dioxygenation to 12(S)-hydro-
peroxy-eicosatetraenoic acid (12(S)-HPETE) is bifurcated in a
reduction route to formation of 12(S)-hydroxy-eicosatetrae-
noic acid (12(S)-HETE) and an isomeration route to forma-
tion of hepoxilins. Hepoxilins are hydroxy^epoxy derivates of
AA, mainly observed as hepoxilin A3 (HXA3) (8S/R-hydroxy-
11,12-epoxyeicosa-5Z,9E,14Z-trienoic acid) and hepoxilin B3
(HXB3) (10S/R-hydroxy-11,12-epoxyeicosa-5Z,8Z,14Z-tri-
enoic acid) ([1] and references therein). HXA3 is a potent
biologically active lipid, which stimulates glucose-induced se-
cretion of insulin in rat pancreatic islets, hyperpolarizes the
membrane potential and controls the inhibitory postsynaptic
potential in aplysia and mammalian neurons, and regulates
the cell volume in platelets and aplysia neurons by activation
of Kþ channels [1]. It has also been shown to augment the
intracellular calcium level [2], the heat shock protein72
(HSP72) [1] as well as AA release and diacylglycerol in human
neutrophils [3].
AA metabolism in mammalian cells is known to be regu-
lated by glutathione peroxidases (GPx) [4^8], which reduce the
hydroperoxy fatty acids emanating from LOXs- or cyclooxy-
genases-catalyzed reactions to corresponding alcohols. Among
various forms of GPx, two di¡erent isoforms, cGPx, the cy-
toplasmic isoform, and PHGPx (phospholipid hydroperoxide
glutathione peroxidase), the membranous isoform, have been
recently reported by us to regulate the 12-LOX-mediated ei-
cosanoid metabolism in platelets [9]. Because GPx and hepox-
ilin-forming catalysts compete for the same substrate, it can
be conjectured that the overall activity of glutathione perox-
idases, or in other words the overall hydroperoxide tone, de-
termines the rate of hepoxilin formation. Consequently, inhi-
bition of both cGPx and PHGPx by iodoacetate has been
shown to enhance the synthesis of hepoxilins with concomi-
tant reduction of 12(S)-HETE production [9]. This indicated a
shift in conversion of 12(S)-HPETE from the reduction path-
way to the so-called isomerization pathway. Although PHGPx
activity contributes only 2% to the total 12(S)-HPETE reduc-
tase activity (mostly cGPx activity) its share in reducing the
12(S)-HPETE is far more pronounced as found in cGPx-de-
pleted selenium-de¢cient UT7 cells [9] and cGPx knock-out
mice [10].
The biosynthesis of hepoxilins by isomerization pathway is
highly controversial. In order to elucidate the mechanism Dr.
Pace-Asciak’s group performed a number of mechanistic stud-
ies during the last decade and proposed an enzymatic pathway
for the formation of hepoxilins. His proposal was based on
the stereoselective conversion of 12(S)-HPETE into 8(S)- and
8(R)-epimers of HXA3 by rat pineal gland [11], while 12(R)-
HPETE remained unmetabolized. Moreover, the conversion
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of AA by the pineal gland resulted in the formation of HXA3
of the native 11(S),12(S)-con¢guration of epoxide, showing
the presence of 12-LOX in the pineal tissue [12], which led
to the conclusion that the biosynthesis of hepoxilins is only
possible in cells and tissues that contain 12-LOX. However, a
clear-cut evidence for the presence of HXA3 synthase activity
is not yet presented. In the present study, we have shown that
RINm5F rat insulinoma cells contain a heat-sensitive leuko-
cyte-type 12-LOX enzyme, which expresses HXA3 synthase
activity and is capable of transforming AA or 12(S)-HPETE
selectively to HXA3. Furthermore, this activity is regulated by
selenoenzymes, e.g. cGPx and PHGPx. To prove the regula-
tion by selenoenzymes, we used native RINm5F cells, which
are devoid of cGPx and PHGPx [13] and produce large
amounts of HXA3 when incubated with AA. The HXA3 syn-
thesis was however abolished when cells stably transfected
with cGPx or PHGPx were used.
2. Materials and methods
2.1. Cell culture
RINm5F, rat insulinoma cells (ATCC, Washington, DC, USA),
were cultured in RPMI 1640 medium supplemented with 10% fetal
calf serum. The cells were grown in humidi¢ed incubators at 37‡C
with 5% CO2. RINm5F cells stably transfected with cGPx, a kind gift
from Dr. Tiedge, Hannover, Germany, were cultured in the same
culture medium as above, but supplemented with 400 Wg/ml geneticin
(Invitrogen) and 10 nM sodium selenite.
2.2. Assay of HXA3 synthase activity
The hepoxilin synthase A3 activity was measured by incubating the
lysate from RINm5F cells with 100 WM AA in a volume of 200 Wl for
30 min at 37‡C and measuring the formation of hepoxilins using GC-
MS or HPLC. The reaction was stopped by acidi¢cation with 1 N
HCl to pH 3.0. The reaction mixture was allowed to incubate at room
temperature in acidic conditions for 15 min before extracting the
lipids twice with 3 volumes of ethyl acetate. The lipid fractions were
extracted with ethyl acetate, evaporated to dryness under nitrogen,
reconstituted in n-hexane and analyzed with gas chromatography-
mass spectrometry (GC-MS).
2.3. GC-MS
The lipids were converted to their methyl esters by the addition of
300 Wl ethereal diazomethane for 5 min. Thereafter the samples were
evaporated to dryness, 30 Wl N-methyl-N-(trimethylsilyl)tri£uoroace-
tamide was added and the mixture was derivatized by heating at 60‡C
for 30 min. GC-MS was performed by means of a Varian Saturn 4D
GC-MS-MS system equipped with a Supelco DB5-MS column
(30 mU0.25 mm; 0.25 WM df). The temperature program was started
at 150‡C increasing to 250‡C within 10 min with a rate of 10‡C/min.
The temperature of injector and transfer line were 230‡C and 220‡C
respectively.
2.4. Detection of HXA3 in RINm5F cells by HPLC
RINm5F cells (10U106 cells) were harvested and resuspended in
100 Wl 0.1 M sodium phosphate bu¡er (pH 7.4). 100 WM AA was
added and the reaction was allowed to proceed at 37‡C for 30 min.
The reaction was stopped and the lipids were extracted by the addi-
tion of ether^methanol^1 M citrate (135:15:1, v/v). The organic phase
was evaporated and the residue was taken into 100 Wl ethyl acetate
and derivatized by the addition of 9-anthryldiazomethane (100 Wg/
reaction) [11]. The reaction mixture was stirred at room temperature
for 1 h. The ethyl acetate was then evaporated, the residue was re-
constituted in the solvent system and the lipids were loaded onto a
Novapk C18 (250U46 mm; 5 Wm particle size) reverse phase column.
Acetonitrile^methanol^water (90:6:4 v/v) was used as mobile phase.
The eluate was UV-monitored using a Shimadzu diode-array detector
set at 254 nm and £uorescence-monitored (excitation 254 nm, emis-
sion 400 nm) using a Shimadzu £uorescence detector.
3. Results
3.1. RINm5F cells express hepoxilin synthase-like activity
Cultured RINm5F cells were incubated with 100 WM AA
for 20 min and the products were analyzed as ADAM ester
derivatives by HPLC monitoring £uorescence detection (see
Section 2). As shown in Fig. 1A, a distinct HXA3 peak was
observed, which appeared at the same retention time as the
authentic standard (panel III). Upon longer incubation, e.g.
40 min, HXA3 peak was substantially reduced and a more
polar peak appeared (not shown), which has been earlier
shown to characterize the hydrolysis products of HXA3, i.e.
8(S/R),11(R),12(S)-trihydroxy-eicosa-5Z,9E,14Z-trienoic acid
and 10(S/R),11(R),12(R)-trihydroxy-eicosa-5Z,8Z,14Z-tri-
enoic acid, trivially known as trioxilins A3 (TrXA3) [1]. As
these hepoxilins are hydrolyzed by cellular epoxide hydro-
lases, HXA3 formation was determined in RINm5F cells pre-
treated with 100 Wg/ml trichloro-propylene oxide (TCPO), an
inhibitor of epoxide hydrolases. After 40 min incubation with
AA a signi¢cant increase in HXA3 formation was observed
A
B
Fig. 1. Representative pro¢les of UV-detectable synthesis of HXA3
untreated (A) and TCPO-treated RINm5F cells. A: Native
RINm5F cells were incubated with 100 WM AA at 37‡C for 30 min.
The lipids were extracted by organic solvents and derivatized by the
addition of 100 Wg 9-anthryldiazomethane. The lipids were separated
by RP-HPLC and detected at 254 nm. Panels I and II represent
HXA3 and HXB3 standard, respectively. Panel III represents the
formation of HXA3 alone from the reaction of AA with RINm5F
cells. Peak next to HXA3 is not related to AA metabolism via 12-
LOX pathway. B: RINm5F cells with or without pretreatment of
10 WM TCPO, an epoxide hydrolase inhibitor, were incubated with
100 WM AA and the samples were processed as described in (A).
Signi¢cant increase in HXA3 formation can be seen in TCPO-
treated cells.
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Fig. 2. Representative mass chromatograms ([M]þ) of Me-TMS derivative of TrXA3 obtained from the transformation of AA by RINm5F
cells. Incubation of RINm5F cells with AA were carried out as described in Fig. 1A and Me-TMS derivatives were analyzed by GC-MS (see
Section 2). A: Panels I and II show the representative mass chromatograms of Me-TMS derivative of standards TrXA3 (m/z 243) and HXB3
(m/z 269), respectively. Panel III shows the representative mass chromatogram of Me-TMS derivative of TrXA3 obtained from the transforma-
tion of AA by native RINm5F cells. Panel IV shows the abrogation of TrXA3 by scanning the mass chromatogram of Me-TMS derivative of
TrXA3 obtained from the reaction of AA with heat-denatured RINm5F cells. B: Electron impact mass spectra of the Me-TMS derivatives of
TrXA3 and HXB3 showing characteristic ions m/z 243 and m/z 269, respectively.
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(Fig. 1B) without appearance of a polar peak. To con¢rm the
chemical structure of HXA3 from RINm5F cells, the incuba-
tion mixture was extracted as described in Section 2, the res-
idue acid-hydrolyzed (to transform HXA3 to stable TrXA3)
and converted to methyl-trimethylsilyl (Me-TMS) derivatives
for GC-MS analysis. As shown in Fig. 2 (panel III), a singular
peak characterizing TrXA3 was observed, but no HXB3 was
detected, indicating the absence of heme-catalyzed reaction.
Fig. 3. Representative mass chromatograms ([M]þ) of Me-TMS derivative of TrXA3 and 12(S)-HETE obtained from the transformation of AA
by native and cGPx-transfected RINm5F cells. Panel I shows the representative mass chromatogram of Me-TMS derivative of TrXA3 (m/z
243) obtained from the transformation of AA by native RINm5F cells. Panel II shows the abrogation of TrXA3 by scanning the mass chroma-
togram of Me-TMS derivative of TrXA3 obtained from the reaction of AA with cGPx-transfected RINm5F cells. Panel III shows the represen-
tative mass chromatogram (m/z 295) of Me-TMS derivative of 12(S)-HETE formed from the reaction of AA with cGPx-transfected RINm5F
cells.
Fig. 4. Production of HXA3 from the transformation of AA by HeLa cells transfected with rat leukocyte-type 12-LOX-cDNA. Panels I and II
show the abrogation of TrXA3 as well as 12(S)-HETE by scanning the mass chromatogram of Me-TMS derivatives of TrXA3 (m/z 243) and
12(S)-HETE (m/z 295), respectively, obtained from the reaction of AA with HeLa cells transfected with rat leukocyte-type 12-LOX. Panels III
and IV show the e¡ect of inhibition of GSH and PHGPx by 2 mM DEM on the formation of TrXA3 as well as 12(S)-HETE, respectively.
Representative mass chromatograms of Me-TMS derivatives of TrXA3 (m/z 243) and 12(S)-HETE (m/z 295), show clearly the formation of
HXA3 as well as 12(S)-HETE by transfected HeLa cells.
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Strikingly, the heat-denatured (90‡C for 10 min) cell lysate
failed to produce any HXA3, pinpointing the enzymatic path-
way of its formation (Fig. 2, panel IV). The absence of 12-
LOX activity as well (not shown) supported the earlier as-
sumption by Pace-Asciak’s group that the HXA3 synthase
activity is only present in cells that contain 12-LOX activity
[12].
3.2. GPx inhibit the formation of HXA3
Recently, we showed the prominent role of PHGPx as a
12(S)-HPETE reductase in human platelets [9]. In absence
of cGPx the reduction 12(S)-HPETE to 12(S)-HETE was tak-
en over by PHGPx. But, inactivation of both selenoenzymes
cGPx and PHGPx by iodoacetate led to accumulation of
12(S)-HPETE, the metabolism of which was consequently di-
verted to HXA3 and HXB3 formation. Since RINm5F cells
are almost devoid of cGPx and PHGPx [13], as expected these
cells synthesized HXA3 when incubated with AA as substrate
(Fig. 3, panel I). Conversely, we assumed that the presence of
GPx should diminish the formation of HXA3 (RINm5F cells
do not produce HXB3 !). Indeed, upon incubation with AA
cultured RINm5F cells, stably transfected with cGPx did not
produce any HXA3 as determined by GC-MS (Fig. 3, panel
II). However, due to the down-regulation of 12-LOX by cGPx
very little 12(S)-HETE was detectable (Fig. 3, panel III). In-
cubation with 12(S)-HPETE of native or cGPx-transfected
RINm5F cells reproduced identical results as with AA (not
shown). Similar results, albeit less pronounced, were obtained
with PHGPx-transfected RINm5F cells (not shown).
3.3. Rat leukocyte-type 12-LOX possesses intrinsic HXA3
synthase-like activity
To investigate if this regulatory mechanism by GPx of 12-
LOX possessing intrinsic HXA3 synthase activity is a common
phenomenon in other cells, we transfected rat leukocyte-type
12-LOX-cDNA in HeLa cells, which show low expression of
12-LOX. Upon incubation of cultured transfected cells with
AA, neither 12(S)-HETE nor HXA3 was produced, suggesting
the complete down-regulation of 12-LOX by selenoenzymes
abundantly present in the cell (Fig. 4, panels I and II). How-
ever, pretreatment of 12-LOX-transfected cells with 2 mM
diethyl maleate (DEM), which depletes cellular glutathione
(GSH) and thus inhibits PHGPx [7], caused signi¢cant en-
hancement of HXA3 synthesis (Fig. 4, panel III), but also a
little formation of 12(S)-HETE. As no HXB3 formation was
detected in GSH- and GPx-depleted cells, an up-regulation of
HXA3 synthase activity seems to be evident.
4. Discussion
Lipoxygenases are bifunctional enzymes exhibiting both
fatty acid dioxygenase and lipohydroperoxidase activities.
The lipohydroperoxidase activity, unlike the dioxygenase ac-
tivity, does not require oxygen insertion. Among various re-
ports on the enzymatic conversion of AA with di¡erent
lipoxygenases, it has been, for instance, clearly demonstrated
that both soybean lipoxygenase-1 [14] and reticulocyte-type
15-lipoxygenase [15] are capable of converting hydroperoxy-
polyenoic fatty acids to their hydroxy^epoxy derivatives.
Thus, 15-LOX has been shown to convert 15-hydroperoxy
fatty acids and AA to epoxy-leukotrienes [15,16]. Also, 15-
LOX from garlic roots converted AA, but not 12(S)-HPETE,
to 14,15-hepoxilins [17]. Although platelet-type 12-LOX does
not possess any lipohydroperoxidase activity, Bryant et al.
showed in the lysate from selenium-de¢cient platelets the for-
mation of hydroxy^epoxy derivatives of AA, currently known
as TrXA3 and TrXB3 [18]. Later, using hemin and hemoglo-
bin Pace-Asciak et al. demonstrated that the isomerization of
12(S)-HPETE to HXA3 and HXB3 is heme-catalyzed [19].
Recently, our laboratory also found that the conversion of
AA to HXA3 and HXB3 in platelets, as reported by Bryant
et al. [8], is heme- and not enzyme-catalyzed, and that cGPx
and PHGPx prevent the detection of hepoxilins by diverting
the 12(S)-HPETEChepoxilin pathway to 12(S)-HPE-
TEC12(S)-HETE pathway [9], thus revealing the importance
of selenoenzymes in the regulatory network of AA metabo-
lism.
RINm5F rat insulinoma cells, which possess leukocyte-type
12-LOX and are devoid of cGPx and PHGPx [13], produced
only HXA3 when incubated with AA (Fig. 1A). Moreover, no
HXA3 was detected in the lysate from heat-inactivated cells
(Fig. 2A, panel IV). But, cultured cells stably transfected with
cGPx or PHGPx-cDNA did not show any formation of
HXA3 (Fig. 3, panel II). These results pinpointed the presence
of HXA3 synthase-like activity in RINm5F cells and its reg-
ulation by GPx. Strikingly, 12-LOX activity was also absent
in heat-denatured RINm5F cells (not shown), which sup-
ported the assumption of Pace-Asciak’s group that the enzy-
matic formation of HXA3 requires inevitably the presence of
12-LOX enzyme [20]. The fact that HeLa cells overexpressing
rat leukocyte-type 12-LOX did not produce any HXA3 and
12(S)-HETE under normal conditions, suggests the complete
down-regulation of 12-LOX activity by the abundantly
present cGPx and PHGPx. But, drastic increase in the forma-
tion of HXA3 upon treatment with DEM, which depletes
cellular GSH and inhibits PHGPx thus elevating the overall
hydroperoxide tone, added support to our assumption that
the rat leukocyte-type 12-LOX possesses an intrinsic HXA3
synthase activity. The latter was found to be ¢nely tuned by
cellular GPx cGPx and PHGPx. This regulation by GPx is in
line with earlier observations reported for 5-, 12- and 15-LOX
[4,6,8].
Normally, in various cell types the presence of GPx exerts
the primacy of the reduction pathway over the hepoxilin path-
way. In our experiments with HeLa cells overexpressing the
rat leukocyte-type 12-LOX, selenoenzymes obviously dimin-
ished the cellular peroxide tone to such an extent that even a
minimum peroxide level essential to trigger the activation of
12-LOX may not be present. Thus, an important message can
be deduced from the above observations, that in most cell
types under physiological conditions abundantly present sele-
noenzymes prevent the hepoxilin formation and divert the AA
metabolism to the formation of 12(S)-HETE from intermedi-
ate 12(S)-HPETE. This means de facto that the formation of
HXA3 is only restricted to pathological cases, say to diseases
with persistent oxidative stress, in which de¢ciency of sele-
noenzymes is prevalent. It should however be stressed that
the mechanisms underlying the activation of HXA3 synthase
activity are primarily associated with GSH depletion and in-
hibition of GPx rather than with increase in reactive oxygen
species. Since HXA3 is know to be cell protective [1], its for-
mation can be regarded as a counteraction to the permanent
oxidative-stressed cellular status. Thus, synthesis of hepoxilins
plays an important role in the processing of cellular hydro-
FEBS 27037 28-2-03
P. Shankaranarayanan et al./FEBS Letters 538 (2003) 107^112 111
peroxides and hence in overall regulation of the 12-LOX path-
way.
Acknowledgements: This study was supported by a Grant from the
Deutsche Forschungsgemeinschaft, Bonn (Ni 242/27-1). Authors wish
to thank Dr. Cecil Pace-Asciak for helpful discussions and sugges-
tions. Authors also express their gratitude to Dr. Tiedge, MH Hann-
over, Germany for native and stably cGPx-transfected RINm5F cells,
Dr. Colin Funk, Philadelphia, PA, USA for p12-LOX-cDNA and Dr.
Brigelius Flohe, Potsdam, Germany for PHGPx plasmid. GC-MS and
LC-MS assistance by Gu«nter Baude, Schering AG, Berlin, Germany is
gratefully acknowledged.
References
[1] Pace-Asciak, C.R. (1994) Biochim. Biophys. Acta 1215, 1^8.
[2] Sutherland, M., Schewe, T. and Nigam, S. (2000) Biochem. Phar-
macol. 59, 435^440.
[3] Nigam, S., Nodes, S., Cichon, G., Corey, E.J. and Pace-Asciak,
C.R. (1990) Biochem. Biophys. Res. Commun. 171, 944^948.
[4] Hatzelman, A., Schatz, M. and Ullrich, V. (1989) Eur. J. Bio-
chem. 180, 527^533.
[5] Weitzel, F. and Wendel, A. (1993) J. Biol. Chem. 268, 6288^6292.
[6] Schnurr, K., Belkner, J., Ursini, F., Schwew, T. and Ku«hn, H.
(1996) J. Biol. Chem. 271, 4653^4658.
[7] Imai, H., Narashima, K., Arai, M., Sakamoto, H., Chiba, N. and
Nakagawa, Y. (1998) J. Biol. Chem. 273, 1990^1997.
[8] Bryant, R.W., Simon, T.C. and Bailey, J.M. (1982) J. Biol.
Chem. 257, 14937^14943.
[9] Sutherland, M., Shankaranarayanan, P., Schewe, T. and Nigam,
S. (2001) Biochem. J. 353, 91^100.
[10] Ho, Y.S., Magnenat, J.L., Bronson, R.T., Cao, J., Gargano, M.,
Sugawara, M. and Funk, C.D. (1997) J. Biol. Chem. 272, 16644^
16651.
[11] Reynaud, D., Demin, P. and Pace-Asciak, C.R. (1994) J. Biol.
Chem. 269, 23976^23980.
[12] Pace-Asciak, C.R., Reynaud, D. and Demin, P. (1995) J. Lipid
Mediat. Cell Signal. 12, 307^311.
[13] Tiedge, M., Lortz, S., Drinkgern, J. and Lenzen, S. (1997) Dia-
betes 46, 1733^1742.
[14] Garssen, G.J., Veldink, G.A., Vliegenthart, J.F. and Boldingh, J.
(1976) Eur. J. Biochem. 62, 33^36.
[15] Bryant, R.W., Schewe, T., Rapoport, S.M. and Bailey, J.M.
(1985) J. Biol. Chem. 260, 3548^3555.
[16] Shimizu, T., Radmark, O. and Samuelsson, B. (1984) Proc. Natl.
Acad. Sci. USA 81, 689^693.
[17] Reynaud, D., Ali, M., Demin, P. and Pace-Asciak, C.R. (1999)
J. Biol. Chem. 274, 28213^28218.
[18] Bryant, R.W., Simon, T.C. and Bailey, J.M. (1983) Biochem.
Biophys. Res. Commun. 117, 183^189.
[19] Pace-Asciak, C.R. (1984) Biochem. Biophys. Acta 793, 485^
488.
[20] Pace-Asciak, C.R., Reynaud, D. and Demin, P. (1995) Lipids 30,
107^114.
FEBS 27037 28-2-03
P. Shankaranarayanan et al./FEBS Letters 538 (2003) 107^112112
